410 related articles for article (PubMed ID: 9389480)
1. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.
Boehm T; Folkman J; Browder T; O'Reilly MS
Nature; 1997 Nov; 390(6658):404-7. PubMed ID: 9389480
[TBL] [Abstract][Full Text] [Related]
2. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene.
Blezinger P; Wang J; Gondo M; Quezada A; Mehrens D; French M; Singhal A; Sullivan S; Rolland A; Ralston R; Min W
Nat Biotechnol; 1999 Apr; 17(4):343-8. PubMed ID: 10207881
[TBL] [Abstract][Full Text] [Related]
3. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.
Kisker O; Becker CM; Prox D; Fannon M; D'Amato R; Flynn E; Fogler WE; Sim BK; Allred EN; Pirie-Shepherd SR; Folkman J
Cancer Res; 2001 Oct; 61(20):7669-74. PubMed ID: 11606410
[TBL] [Abstract][Full Text] [Related]
4. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
5. Zinc-binding of endostatin is essential for its antiangiogenic activity.
Boehm T; O'reilly MS; Keough K; Shiloach J; Shapiro R; Folkman J
Biochem Biophys Res Commun; 1998 Nov; 252(1):190-4. PubMed ID: 9813168
[TBL] [Abstract][Full Text] [Related]
6. A cancer therapy resistant to resistance.
Kerbel RS
Nature; 1997 Nov; 390(6658):335-6. PubMed ID: 9389468
[No Abstract] [Full Text] [Related]
7. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
8. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
[TBL] [Abstract][Full Text] [Related]
9. [Anti-angiogenetic therapy of tumors in the animal experiment].
Strahlenther Onkol; 1998 Jun; 174(6):336-8. PubMed ID: 9645219
[No Abstract] [Full Text] [Related]
10. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.
Miao WM; Seng WL; Duquette M; Lawler P; Laus C; Lawler J
Cancer Res; 2001 Nov; 61(21):7830-9. PubMed ID: 11691800
[TBL] [Abstract][Full Text] [Related]
11. Soluble recombinant endostatin purified from Escherichia coli: antiangiogenic activity and antitumor effect.
Huang X; Wong MK; Zhao Q; Zhu Z; Wang KZ; Huang N; Ye C; Gorelik E; Li M
Cancer Res; 2001 Jan; 61(2):478-81. PubMed ID: 11212235
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of angiostatin and ionizing radiation in antitumour therapy.
Mauceri HJ; Hanna NN; Beckett MA; Gorski DH; Staba MJ; Stellato KA; Bigelow K; Heimann R; Gately S; Dhanabal M; Soff GA; Sukhatme VP; Kufe DW; Weichselbaum RR
Nature; 1998 Jul; 394(6690):287-91. PubMed ID: 9685160
[TBL] [Abstract][Full Text] [Related]
13. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
14. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
Sauter BV; Martinet O; Zhang WJ; Mandeli J; Woo SL
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4802-7. PubMed ID: 10758166
[TBL] [Abstract][Full Text] [Related]
16. Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium.
Solaun MS; Mendoza L; De Luca M; Gutierrez V; López MP; Olaso E; Lee Sim BK; Vidal-Vanaclocha F
Hepatology; 2002 May; 35(5):1104-16. PubMed ID: 11981760
[TBL] [Abstract][Full Text] [Related]
17. Anticancer treatment of endostatin gene therapy by targeting tumor neovasculature in C57/BL mice.
Jia S; Zhu F; Li H; He F; Xiu R
Clin Hemorheol Microcirc; 2000; 23(2-4):251-7. PubMed ID: 11321448
[TBL] [Abstract][Full Text] [Related]
18. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
19. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus.
Yamanaka R; Zullo SA; Ramsey J; Onodera M; Tanaka R; Blaese M; Xanthopoulos KG
Cancer Gene Ther; 2001 Oct; 8(10):796-802. PubMed ID: 11687903
[TBL] [Abstract][Full Text] [Related]
20. Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours.
Jazowiecka-Rakus J; Jarosz M; Szala S
Acta Biochim Pol; 2006; 53(1):199-202. PubMed ID: 16388313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]